Condensed Consolidated Statements of Operations - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Revenues:
Total revenues
Operating expenses:
Research and development	68,271	54,873	174,699	152,275
General and administrative	12,141	8,287	33,573	25,606
Total operating expenses	80,412	63,160	208,272	177,881
Loss from operations	(80,412)	(63,160)	(208,272)	(177,881)
Interest income	717	60	1,109	311
Interest expense	(1,502)	0	(2,282)	0
Other income		0		273
Net loss	$ (81,197)	$ (63,100)	$ (209,445)	$ (177,297)
Net loss per common share:
Earnings Per Share, Basic	$ (4.75)	$ (3.79)	$ (12.25)	$ (10.84)
Earnings Per Share, Diluted	$ (4.75)	$ (3.79)	$ (12.25)	$ (10.84)
Weighted Average Number of Shares Outstanding, Basic	17,103,395	16,639,776	17,103,395	16,353,428
Weighted Average Number of Shares Outstanding, Diluted	17,103,395	16,639,776	17,103,395	16,353,428